NuVasive Announces Upcoming Departure of Chief Financi... ( SAN DIEGO Sept. 2 /...)

NuVasive Announces Upcoming Departure of Chief Financial Officer

Date:9/2/2009

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Executive Vice President & Chief Financial Officer, has informed NuVasive of his resignation from his position so that he is able to attend to personal and family obligations. The Company is currently engaged in a search for a new Chief Financial Officer. Mr. O'Boyle plans to remain with the Company until December 31, 2009, or potentially longer, to assist in the recruitment of his replacement and to effect an orderly transition.

"I have thoroughly enjoyed serving as part of the management team of NuVasive, helping to build the Company into a major player in the spine industry with a unique culture of Absolute Responsiveness," Mr. O'Boyle said. "Unfortunately, personal obligations make a long term position as CFO of NuVasive extremely difficult to maintain. I would like to thank all NuVasive shareowners for making my time at NuVasive a remarkable one."

Alex Lukianov, Chairman and Chief Executive Officer, said, "Kevin has been part of our executive team for the past 6 years, from fundraising as a private company, to our initial public offering, to helping build our corporate infrastructure for long term growth and continued market share gains. We thank him for his contributions to the Company and wish him well as he attends to important family and personal matters."

Mr. Lukianov continued, "Our financial and business condition is vibrant and healthy as we continue to expand our presence in the market. We have begun the comprehensive search process to identify a new CFO and will be conducting a thorough review to identif
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
9. NuVasive Reports First Quarter 2008 Financial Results
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference

Post Your Comments:

(Date:6/18/2013)... June 18, 2013 Seven-year-old Riley Salz ... from autism. He receives 40 hours a week of ... shadowing) from the Center for Autism and Related Disorders ... August, 2008, and has experienced remarkable progress, including learning ... his environment. Riley’s personal journey through autism is now ...

(Date:6/18/2013)... has shown that cancer cells have a much different ... Now, scientists at The University of Texas at Dallas ... new strategy to combat lung cancer. , In an ... PLOS ONE , UT Dallas researchers compared the metabolic ... cells taken from the same patient. , They ...

(Date:6/18/2013)... new commercial venture, using technology developed at Case ... and Case School of Engineering, has made available ... allows graduate students and others training to evaluate ... program, reducing stress on the trainee, because a ... real person. , Graduate students studying to ...

(Date:6/18/2013)... More than 1.1 million people in the U.S. ... the Centers for Disease Control and Prevention (CDC). Of those, ... of National HIV Testing Day on June 27, Allsup, a ... representation, the CDC and other organizations are raising awareness of ... about 50,000 new HIV infections each year. Along with developing ...

(Date:6/18/2013)... The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) joined ... Emergency Plan for AIDS Relief (PEPFAR) to mark PEPFAR’s ... the global effort to eliminate pediatric HIV/AIDs. U.S. ... June 2013, one million babies globally have been born ... in 2003, EGPAF has been a key implementer of ...

Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UT Dallas study suggests new approach to fight lung cancer 2 Health News:UT Dallas study suggests new approach to fight lung cancer 3 Health News:SimuCase avatars advance speech-language pathology training 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2 Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3

[0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UT Dallas study suggests new approach to fight lung cancer [0] SimuCase avatars advance speech-language pathology training [0] Allsup Observes National HIV Testing Day June 27 [0] One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS

... visually impaired, navigating city streets or neighborhoods has constant challenges. ... rudimentary technologya simple caneto help them make their way through ... California engineering researchers is working to change that by developing ... design first shown a year ago is now being further ...

... Steven Reinberg HealthDay Reporter , WEDNESDAY, May ... prescribed drugs, the antidepressant Paxil and the cholesterol-lowering medication ... new study finds. The increase is most apparent ... is already too high, the researchers noted. "This ...

... 2011) The Maryland Stem Cell Research Commission (Commission) ... in response to its three FY 2011 Requests for ... Technology Development Corporation (TEDCO) approved the Commission,s recommendation to ... Research Fund,s (MSCRF) $10.4 million FY 2011 budget. ...

... May 25 (HealthDay News) -- The Internet has put the ... also allowed banned or controlled substances to slip within their ... online May 19 in Drug Testing and Analysis , ... contain ingredients other than those claimed and can be hazardous. ...

... obese women with less-than-optimal levels of vitamin D who lose ... increases in circulating levels of this fat-soluble nutrient, according to ... Center. , "Since vitamin D is generally lower in persons ... account, in part, for the link between obesity and diseases ...

... known for years that playing violent video games causes ... a new University of Missouri (MU) study provide one ... video game players become less responsive to violence, and ... "Many researchers have believed that becoming desensitized to ...

Cached Medicine News:Health News:'Guide vests' -- robotic navigation aids for the visually impaired 2 Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 2 Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 3 Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 2 Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 3 Health News:Illegal Drugs Easy to Buy on the Internet, U.K. Study Finds 2 Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 2 Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 3 Health News:Violent video games reduce brain response to violence and increase aggressive behavior 2

'Guide vests' -- robotic navigation aids for the visually impaired Combo of Paxil, Pravachol May Raise Blood Sugar Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 Illegal Drugs Easy to Buy on the Internet, U.K. Study Finds Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women Violent video games reduce brain response to violence and increase aggressive behavior

(Date:6/18/2013)... 18, 2013 Decision Resources, one of the world,s ... finds that, over the past 12 months, 25 percent of ... Germany , Italy , ... Kingdom ) have been required to change the antiretroviral ... primarily to reduce costs. Additionally, more than 40 percent of ...

(Date:6/18/2013)... YORK , June 18, 2013 JDRF and ... are accelerating the development of new products that combine BD,s ... collaboration announced today. This new, three-year commitment is an extension ... Many patients with T1D not only take daily ... be placed in the body for a number of days ...

(Date:6/18/2013)... 18, 2013 Today, Wall Street Reports ... GILD ), Health Management Associates Inc. (NYSE: ... ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius ... free of charge - including full price targets, industry analysis ... Gilead Sciences, Inc. Research Report On June 7, ...

Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2 One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6

[0] One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs [0] JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes [0] Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics

... presented at,the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) ... continue,to offer new and better treatment options for breast ... for longer if the medicines are,given before and after ... , , Key data ...

... Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced ... AZ-004 (Staccato(R) loxapine). This Phase 3,clinical trial was ... Both the 5 mg and 10 mg doses of ... a statistically significant reduction in,agitation from baseline to the ...

New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial

Inquire...

... Anatomical Malar I Implants - Providing ... implant follows the contour of the zygoma ... prominence. Anatomical Malar II Implants - ... the surgeon with another augumentation option that ...

... - Anatomically designed to enhance the chin contour, ... mandible with a high-profile central chin projection. ... entire mandible, this implant provides a high central ... arms. Cleft Chin Implants - Designed with ...

Medicine Products:

Surgiform® Nasal Implants Taylor Posterior Mandibular Angle™ Implant Augmentation Malar Implants Extended Chin Implants